Kidney Function in Diabetics During CPB (Cardio Pulmonary Bypass)
NCT ID: NCT03405532
Last Updated: 2024-04-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
SUSPENDED
30 participants
OBSERVATIONAL
2018-01-11
2030-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Cardiopulmonary Bypass Flow on Renal Oxygenation, Blood Flow and Tubular Injury
NCT04084301
Renal Perfusion, Filtration and Oxygenation During Cardiopulmonary Bypass (CPB)
NCT02405195
Impact of CArdiopulmonary Bypass Flow on Renal Blood Flow, Function and OXygenation
NCT02549066
Diagnostic Accuracy Study of a Point-of-Care Test for Coagulation Function
NCT06037720
Effects of Hyperglycemia During Cardiopulmonary Bypass on Renal Function
NCT00404950
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
DM-ECC
Diabetes mellitus CPB
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Serum creatinine \< 150 micromol/L preoperative
* Heart surgery requiring CPB
* LV (left ventricle) EF \>40 %
* Normal hemoglobin
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sahlgrenska University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Maria Tholén
Principal investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sven-Erik Ricksten, Prof
Role: PRINCIPAL_INVESTIGATOR
Sahlgrenska Universitetssjukhuset
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sahlgrenska University Hospital
Gothenburg, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SahlgrenskaUHMT02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.